FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

714420001: Paritaprevir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3299002014 Paritaprevir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3299459015 Paritaprevir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3299002014 Paritaprevir (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3299002014 Paritaprevir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3299459015 Paritaprevir en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3299459015 Paritaprevir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
831291000172112 paritaprévir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831291000172112 paritaprévir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paritaprevir (substance) Is a Hepatitis C virus NS3/4A protease inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Paritaprevir (substance) Has disposition Hepatitis C virus NS3/4A protease inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Paritaprevir-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing ombitasvir and paritaprevir and ritonavir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing paritaprevir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 4
Dasabuvir- and ombitasvir- and paritaprevir- and ritonavir-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 4
Product containing only dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 4
Paritaprevir only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ombitasvir and paritaprevir and ritonavir only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only paritaprevir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only dasabuvir and ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 4
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Paritaprevir (substance) Inferred relationship Existential restriction modifier (core metadata concept) 3

This concept is not in any reference sets

Back to Start